Rena Kaminsky
About Rena
Rena Kaminsky represents biotechnology, medical device, and other public and private life sciences companies in a wide range of intellectual property and commercial transactions, including corporate partnering, licenses, research and development collaborations, and manufacturing and supply arrangements.
Experience
-
Valneva Announces up to $500 Million Debt Facility With Pharmakon Advisors
-
SiteOne Therapeutics to Be Acquired by Eli Lilly for up to $1 Billion
-
Brii Biosciences Announces Agreements to Acquire VBI Vaccines’ IP Rights in BRII-179
-
Gracell Biotechnologies Agrees to Acquisition by AstraZeneca for up to $1.2 Billion
-
SystImmune Announces Global Strategic Collaboration With Bristol Myers Squibb
Admissions and credentials
- California
- Registered to practice before the United States Patent and Trademark Office (USPTO)
Memberships and affiliations
- American Bar Association (ABA)
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.